Mitigating the risk of complications in your hospital’s most expensive and most critical cases

Join us to learn the results of the INVOSTM system Comparative Effectiveness Analysis

Tuesday, September 29, 2015 | 2:00PM -3:00PM CT

Last year, Medtronic selected a number of geographically, demographically, and economically diverse hospitals to participate in a comparative effectiveness analysis of cardiac surgery procedures using INVOS™ cerebral/somatic oximetry. We partnered with PotentiaMED, an objective third party to collect de-identified patient data and use the power of advanced analytics to quantify the impact of INVOS monitoring on outcomes.

The initial results are clinically relevant and economically powerful.

We cordially invite you to attend this webinar to discuss:

  • Cardiac surgery outcomes at top hospitals and the overall value of the INVOS system
  • Reduction in costs of care respective to complications such as post-op MOMM, neurologic injury and extended length of stay (LOS)
  • Potential impact on patient satisfaction, hospital safety rankings and hospital differentiation

Guest Presenter:


Corporate Presenters:


Did the INVOS™ system succeed in mitigating the risks associated with vital organ compromise
in the pilot hospitals’ most expensive and critical cases? Join us on September 29 to find out.